skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,
We need some help with revamping our health care stock strategy. Money not needed for 10 -15 years. Our health care stocks are SIS, GUD, Gilead, and PLI. We are underwater on all except SIS (thx it's been a great performer). I'd like to sell Gilead (owned for about 3-4 years and down 20%) and come up with a better US$ pick since there are so many more options in the states. What would be your best suggestion?
Thanks,
Kerri
Read Answer Asked by KERRI on January 24, 2018
Q: I own the above noted stocks relating to healthcare at roughly 1% weighting each. I am fine with hanging onto GUD and waiting but I was wondering if the other two are worth hanging onto or if I should move onto something else in the sector.
When adding more (approximately 5 to 10% of overall portfolio) to this sector would you recommend an etf or specific stocks?
Any recommendations (Canada, US or Int'l) would be greatly appreciated.
Thanks.
Brian
Read Answer Asked by Brian on January 15, 2018
Q: I have small position in CELG (about 2%). With the recent weakness in the last week, would you suggest holding onto it, or even buying more? If I were to sell is there another healthcare stock you would suggest?
Read Answer Asked by Curtis on October 30, 2017
Q: US STOCKS - GE AND K - HITTING LOWS - DO YOU SEE VALUE IN HERE AND IS IT OK TO ADD. OR YOU WOULD PREFER IN STRENGTH - HON AND GILD WITH THEIR RECENT DEVELOPMENTS. SAFETY AND INCOME AND SHARE PRICE APPRECIATION, IS GOAL.
Read Answer Asked by RUPINDER on October 11, 2017
Q: Good Morning Team,

Would you switch NXPI for GIlD?

NXPI isn't really going anywhere after the cash offer by Qualcomm (is it still on?) and has no dividend.
After the initial hesitation, the recent deal by GILD seems to be welcomed by the market.

So, I guess my question is: which one has the most upside potential at this point?

As always,thanks for your wise input.
Read Answer Asked by Saeed on September 01, 2017
Q: Well, Gilead Sciences finally made there acquisition with their cash. Some say they should have brought Kite Pharma one year ago and overpay for it today. In addition, they say the Kite takeover will not be accretive for three years, What are your views and opinions on the deal that Gilead Sciences made for Kite Pharma?
Read Answer Asked by Herbert on August 30, 2017
Q: My primary investment objective is to find companies with growth potential with a secondary goal for some dividend income. I bought Innergex renewable (INE) a year ago at 14.80. This year it has been flat around 14.50. I am considering selling it and reinvesting the proceeds into Gilead (GILD). With GILD there is also the potential of some currency appreciation. Please let me have your thoughts. Is there another Company you would prefer to Gilead??
Read Answer Asked by Bob on July 21, 2017
Q: Would you put money into biotech seasonally ? In the past I have done well on Celgene ... However , I have taken quite a hit on Gillead, so I am cautious.
Or should I look at the ETFs for a broader/safer play ?
Read Answer Asked by Thomas on June 20, 2017
Q: Hi All at 5i!!! I know that you don't follow Us stocks BUT...if you had to choose one of the following for a long term hold, which would it be ? Cheers, Tamara...PS. I really hope you will create a Us stock portfolio....just saying....😁😁😁
Read Answer Asked by Tamara on May 15, 2017
Q: I'm holding about 5% of my investments in cash in a US dollar account and looking to invest in a blue chip dividend paying stock. Maybe one of the two above or another name you like. I'm 80 so dividend and low risk is what I would like to find.
Thanks for your great service

Read Answer Asked by Greg on May 05, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!